Company News

Proteon Pharmaceuticals, polska firma biotechnologiczna i lider technologii bakteriofagowej w dodatkach paszowych dla zwierząt hodowlanych, podjęła strategiczne partnerstwo z DuPont Animal Nutrition, oddziałem DuPont Nutrition & Biosciences (DuPont),  w zakresie dystrybucji innowacyjnych rozwiązań Proteonu. Celem współpracy jest wprowadzenie w wybranych krajach oferowanych przez Proteon rozwiązań bakteriofagowych dla producentów drobiu. Dzięki znanej i zaufanej marce lidera […]

Read More

The partnership will bring the emerging bacteriophage technology to poultry producers to help mitigate antimicrobial resistance. Warsaw, September 9, 2020 – Proteon Pharmaceuticals, a Polish biotechnology company and leader in bacteriophage technology for livestock farming, today announced a strategic partnership with DuPont Animal Nutrition, a business unit of DuPont Nutrition & Biosciences (DuPont) in distribution […]

Read More

In response to the fight against coronavirus, Proteon Pharmaceuticals has joined the effort to create a new SARS-CoV-2 Coronavirus Detection Center in Lodz, Poland to conduct large-scale tests for virus diagnosis. The new laboratory was created at a very fast pace with the involvement and cooperation of the Institute of Medical Biology of the Polish […]

Read More

Ważny krok w walce z koronawirusem – w Łodzi powstało nowe Centrum Wykrywania Koronawirusa SARS-CoV-2 umożliwiające wykonywanie dużej liczby testów na obecność wirusa. Laboratorium powstało w bardzo szybkim tempie dzięki zaangażowaniu i współpracy Instytutu Biologii Medycznej PAN, Wydziału Biologii i Ochrony Środowiska Uniwersytetu Łódzkiego, Uniwersytetu Medycznego w Łodzi oraz firmy Proteon Pharmaceuticals S.A.  Kluczowym dla […]

Read More

A Łódź pharmaceutical company has received over 2 million Euros to reduce animal antibiotics in the human food chain. In an attempt to find a solution to the well-known overuse of antibiotics in animals farmed for human consumption, the use of which has led to an increase in antibiotic resistant bacteria strains, Proteon Pharma has […]

Read More

Polish biotech company Proteon Pharmaceuticals S.A, a global leader in the development and commercialization of bacteriophages for industrial use in livestock farming in poultry, dairy and aquaculture, has been awarded 2,9 mln Euro by the European Regional Development Fund to design and implement products that reduce the need for antibiotics in the human food chain. […]

Read More

Proteon Receives “2019 Animal Health Innovation Award” at the Animal Health Investment Europe Conference in London, UK.. COO and Board Member Matthew Tebeau accepted the award on Proteon’s behalf.   Animal Health Investment Europe is dedicated to showcasing to investors the most innovative emerging animal health companies covering the companion, aquaculture and production animal space. Proteon […]

Read More

Proteon Founder and Board Member, Professor Jarosław Dastych, made a major presentation at the Bacteriophage Therapy Summit in  Boston, USA. He spoke on the  topic  of ” Aquaculture: Challenges and Lessons of Product Development” The Bacteriophage Therapy Summit is the only meeting uniting large pharma, biotech companies, research institutions and technology experts to harness bacteriophage science and accelerate the clinical […]

Read More

Proteon received the Best “Innovation in Aquaculture Award”, from His Excellency, Saeed Albahri Salem Alameri, and Hans van der Beek, Director General of the Abu Dhabi Agriculture and Food Safety Authority at the Global Forum for Innovations in Agriculture (GFIA) in Abu Dhabi. Tom Cook, VP. Global Business Development at Proteon Pharmaceuticals, accepted the award. The […]

Read More